| - Industry | - Sector | - CEO | XNSE Exchange | - ISIN |
| India Country | 293 Employees | - Last Dividend | - Last Split | - IPO Date |
Sai Parenteral's Ltd is a prominent pharmaceutical formulations company dedicated to the research, development, and manufacturing of branded generic formulations. The organization also offers contract development and manufacturing organization (CDMO) services, catering to both domestic and international markets. With a diverse product portfolio, Sai Parenteral's Ltd addresses multiple therapeutic areas including cardiovascular health, neuropsychiatry, anti-diabetic therapies, respiratory health, antibiotics, gastroenterology, vitamins, minerals and supplements, analgesics, and dermatology. The company's expertise extends to a range of dosage forms such as injectables, tablets, capsules, liquid orals, and ointments, alongside specialized capabilities in sterile manufacturing for critical care applications and penicillin-based therapies. This includes the production of dry powder injections, pre-filled syringes, ampoules, and vials. Established in 2001 and headquartered in Hyderabad, Telangana, Sai Parenteral's Ltd plays an integral role in supplying high-quality pharmaceutical products to healthcare sectors globally, while operating five manufacturing facilities across India, accredited with various quality certifications including GMP compliance, WHO-GMP, TGA-Australia, and PIC/S accreditation.
A range of medications designed to treat heart conditions, including hypertension and heart failure, contributing to improved cardiovascular health.
Medications focusing on mental health disorders, providing treatment options for conditions like depression, anxiety, and schizophrenia.
An array of products aimed at managing diabetes, helping to regulate blood sugar levels through both oral and injectable formulations.
Formulations addressing respiratory issues such as asthma and chronic obstructive pulmonary disease (COPD), improving patients' respiratory function.
A diverse selection of antibiotics utilized for treating bacterial infections, ensuring effective management of various infectious diseases.
Medications targeting gastrointestinal disorders, aimed at treating conditions like acid reflux, ulcers, and inflammatory bowel diseases.
A portfolio of nutritional supplements designed to support overall health and wellness, filling dietary gaps and enhancing health outcomes.
Pain relief medications for various degrees of pain, ensuring comfort for patients in both acute and chronic pain management scenarios.
A specialized focus on sterile products, including dry powder injections and pre-filled syringes, catering to critical care needs in various healthcare settings.
Offering comprehensive CDMO services, Sai Parenteral's Ltd collaborates with pharmaceutical companies to develop, manufacture, and market high-quality formulations.